SCHEMBL7764282

SCHEMBL7764282

C=C1/C(=C\C=C2CCC[C@@]3(C)C2CC[C@@H]3[C@H](C)CCC[C@](C)(O)CC(=O)OCC)C[C@@H](O)C[C@H]1O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ VDR P11473 12/20 0.75
▸ MAPT P10636 2/20 0.75
▸ ADORA3 P0DMS8 2/20 0.75
▸ SLC6A2 P23975 2/20 0.75
▸ AGTR1 P30556 2/20 0.75
▸ NR1I2 O75469 1/20 0.75
▸ ABCB11 O95342 1/20 0.75
▸ GC P02774 1/20 0.75
▸ PGR P06401 1/20 0.75
▸ RXRA P19793 1/20 0.75
▸ CHRM3 P20309 1/20 0.75
▸ CNR1 P21554 1/20 0.75
▸ HTR2C P28335 1/20 0.75
▸ MAPK1 P28482 1/20 0.75
▸ SLC6A4 P31645 1/20 0.75
▸ ADRA1A P35348 1/20 0.75
▸ PTGS2 P35354 1/20 0.75
▸ OPRD1 P41143 1/20 0.75
▸ OPRK1 P41145 1/20 0.75
▸ SLC6A3 Q01959 1/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7763268 1.00 VDR (0.75) VDRMAPTADORA3SLC6A2AGTR1
SCHEMBL7764237 0.90 VDR (0.81) VDRMAPTADORA3SLC6A2AGTR1
SCHEMBL7764783 0.90 VDR (0.81) VDRMAPTADORA3SLC6A2AGTR1
SCHEMBL7760573 0.90 VDR (0.81) VDRMAPTADORA3SLC6A2AGTR1
SCHEMBL6846636 0.88 VDR (0.68) VDRMAPTADORA3SLC6A2AGTR1
SCHEMBL23359068 0.87 VDR (0.86) VDRMAPTADORA3SLC6A2AGTR1
SCHEMBL11165113 0.87 VDR (0.86) VDRMAPTADORA3SLC6A2AGTR1
SCHEMBL9722601 0.87 VDR (0.86) VDRMAPTADORA3SLC6A2AGTR1
SCHEMBL10892402 0.87 VDR (0.86) VDRMAPTADORA3SLC6A2AGTR1
SCHEMBL9722603 0.87 VDR (0.86) VDRMAPTADORA3SLC6A2AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0854138-B1 Vitamin D3 derivative and production process thereof TEIJIN LTD (JP) 2001-05-23 — — EP disclosed
US-6177586-B1 USEFUL AS A PHARMACEUTICAL SUCH AS AN AGENT FOR PROMOTING BONE FORMATION, AN AGENT FOR SUPPRESSING PROLIFERATION OF TUMOR CELLS, AN AGENT FOR HIGH CALCIUM BLOOD DISEASES, AND AN IMMUNOSUPPRESSION AGENT TEIJIN LIMITED (JP) 2001-01-23 — — US disclosed
EP-0854138-A2 Vitamin D3 derivative and production process thereof TEIJIN LIMITED (JP) 1998-07-22 — — EP disclosed
EP-0712843-A1 VITAMIN D3 DERIVATIVE AND PROCESS FOR PRODUCING THE SAME TEIJIN LIMITED (JP) 1996-05-22 — — EP disclosed
Send feedback